Sponsor or institution
Clinical trials and research at AAVantgarde Bio Srl
As of November 12, 2026, Find a Trial lists 2 clinical trials run by AAVantgarde Bio Srl that are recruiting, at sites in 4 countries (most in United Kingdom (2), Italy (1), Norway (1)). By phase: Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 4Countries
All recruiting trials (2)
-
AAVB-039 gene therapy for Stargardt disease
This study will test a single subretinal injection of AAVB-039 gene therapy in people with Stargardt disease caused by two ABCA4 mutations to see if it is safe and shows early benefit.
-
Injecting AAVB-081 to treat Usher Syndrome Type IB
This study is testing a new injection for people with Usher Syndrome Type IB to see if it is safe and helps improve their vision.
Quick answers
How many clinical trials run by AAVantgarde Bio Srl are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United Kingdom (2 trials), Italy (1 trial), Norway (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.